Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Biostatistics (Oxford, England)|January 28, 2004
Composite likelihood and two-stage estimation in family studiesElisabeth Wreford Andersen
Lifetime Data Analysis|September 1, 2005
Two-stage estimation in copula models used in family studiesElisabeth Wreford Andersen
Statistics in Medicine|November 19, 2002
Adjustment for misclassification in studies of familial aggregation of disease using routine register dataElisabeth Wreford Andersen, Per Kragh Andersen
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 15, 2005
Escitalopram versus paroxetine for social anxiety disorder: an analysis of efficacy for different symptom dimensionsDan J Stein, Elisabeth Wreford Andersen, Malcolm Lader
Current Medical Research and Opinion|April 5, 2007
Escitalopram in obsessive-compulsive disorder: a randomized, placebo-controlled, paroxetine-referenced, fixed-dose, 24-week studyDan J Stein, Elisabeth Wreford Andersen, Brigitte Tonnoir, et al.
Brain, Behavior, and Immunity|March 16, 2026
Infectious biomarkers in patients with primary mental Disorders: A comprehensive systematic review and Meta-AnalysisVardan Nersesjan, Benjamin Noer Larsen, Elisabeth Wreford Andersen, et al.
Depression and Anxiety|January 12, 2005
Escitalopram in the treatment of social anxiety disorder: analysis of efficacy for different clinical subgroups and symptom dimensionsDan J Stein, Siegfried Kasper, Elisabeth Wreford Andersen, et al.
Scandinavian Journal of Public Health|March 31, 2015
Reduction in pedometer-determined physical activity in the adult Danish population from 2007 to 2012Jeppe Matthiessen, Elisabeth Wreford Andersen, Anders Raustorp, et al.
European Journal of Nutrition|January 5, 2018
Modelling of adequate and safe vitamin D intake in Danish women using different fortification and supplementation scenarios to inform fortification policiesIda M Grønborg, Inge Tetens, Majken Ege, et al.
The Lancet. Psychiatry|September 6, 2024
Antipsychotic exposure and infection risk in people with schizophrenia spectrum disorders during the COVID-19 pandemic: a Danish nationwide registry studyVardan Nersesjan, Rune H B Christensen, Elisabeth Wreford Andersen, et al.
Pageof 4